News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
Presentation TCT 2024 TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease Presenter: Francesco Giannini October 30, 2024
Presentation TCT 2024 Case 2: Protect the Coronary! Low Left Main and Effaced Sinuses Presenter: Karim Al-Azizi October 30, 2024
Presentation TCT 2024 TCT 323: Evaluating the Efficacy of Coronary Sinus Aspiration During Coronary Angioplasty to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients Presenter: SOMIL VERMA October 28, 2024
Presentation TCT 2024 TCT 673: Coronary Sinus Reducer for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA) Presenter: Maayan Konigstein October 27, 2024
Presentation TCT 2024 TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO) Presenter: Maayan Konigstein October 27, 2024
Presentation TCT 2024 TCT 1463: Improvement in Coronary Microcirculatory Function With A-FLUX Next-Generation Coronary Sinus Reducer Presenter: Manel Sabate October 27, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024
News Conference News EuroPCR 2024 ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI Shelley Wood May 16, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
Presentation ACC 2024 Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC) Presenter: Rasha K. Al-Lamee April 08, 2024
Presentation THT 2024 Right Left Atrial-to-Coronary Sinus Shunting: The APTURE Program Presenter: Firas Zahr March 04, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants Shelley Wood January 17, 2024